# A Study to Investigate Using Inhaled Fexlamose to Treat Adult Participants Who Have Moderate to Severe COPD

> **NCT06731959** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Aer Therapeutics** · enrollment: 100 (estimated)

## Conditions studied

- COPD

## Interventions

- **DRUG:** Flexlamose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06731959
- **Lead sponsor:** Aer Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12
- **Primary completion:** 2025-11
- **Final completion:** 2026-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06731959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06731959, "A Study to Investigate Using Inhaled Fexlamose to Treat Adult Participants Who Have Moderate to Severe COPD". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06731959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*